Ohcanbohtosat - J.C. Angulo
- Čájehuvvo 1 - 13 / 13
-
1
-
2
The Changing Therapeutic Landscape of Metastatic Renal Cancer Dahkki J.C. Angulo, Oleg Shapiro
Almmustuhtton 2019Revisão -
3
-
4
Hot Spots in Urological Basic Cancer Research and Clinics Dahkki Claudia Manini, Gorka Larrinaga, J.C. Angulo, José I. López
Almmustuhtton 2025Pré-impressão -
5
Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial Dahkki Vik Khullar, J. Cambronero, J.C. Angulo, M. Wooning, Mary Beth Blauwet, Caroline A. Dorrepaal, Nancy Martin
Almmustuhtton 2013Artigo -
6
Dual specificity phosphatase 1 expression inversely correlates with NF‐κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism... Dahkki Beatriz Gil-Araujo, M. Val Toledo-Lobo, María Teresa Gutiérrez‐Salmerón, Julia Gutiérrez-Pitalúa, Santiago Ropero, J.C. Angulo, Antonio Chiloeches, Marina Lasa
Almmustuhtton 2013Artigo -
7
Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Ran... Dahkki Fritz H. Schröder, Chris Bangma, J.C. Angulo, Antonio Alcaraz, Marc Colombel, Tom McNicholas, Teuvo L.J. Tammela, Indrani Nandy, Ramiro Castro
Almmustuhtton 2012Artigo -
8
The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases Dahkki Peio Errarte, Rosa Guarch, Rafael Pulido, Lorena Blanco, Caroline E. Nunes‐Xavier, Maider Beitia, Javier Gil, J.C. Angulo, José I. López, Gorka Larrinaga
Almmustuhtton 2016Artigo -
9
Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment Dahkki Gorka Larrinaga, Miriam Redrado, Ana Loizaga‐Iriarte, Amparo Pérez-Fernández, Aida Santos-Martín, J.C. Angulo, José A. Fernández, Alfonso Calvo, José I. López
Almmustuhtton 2025Artigo -
10
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase... Dahkki Victor W. Νitti, V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn, J. Cambronero, J.C. Angulo, Mary Beth Blauwet, Caroline A. Dorrepaal, Emad Siddiqui, Nancy Martin
Almmustuhtton 2013Artigo -
11
Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma Dahkki Gorka Larrinaga, Jon Danel Solano-Iturri, Peio Errarte, Miguel Unda, Ana Loizaga‐Iriarte, Amparo Pérez-Fernández, E. Echevarría, Aintzane Asumendi, Claudia Manini, J.C. Angulo, José I. López
Almmustuhtton 2021Artigo -
12
Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis Dahkki Joshua Sterling, Jay Simhan, Brian J. Flynn, Paul Rusilko, Wagner A. França, Erick A. Ramírez, J.C. Angulo, Francisco E. Martins, Hiren V. Patel, Margaret Higgins, Daniel Swerdloff, Dmitriy Nikolavsky
Almmustuhtton 2024Artigo -
13
Efficacy and safety of a hexanic extract of <i>Serenoa repens</i> (Permixon<sup>®</sup>) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperpla... Dahkki R. Vela‐Navarrete, Antonio Alcaraz, A. Rodrı́guez-Antolı́n, B. Miñana, J.M. Fernández Gómez, J.C. Angulo, David Castro‐Díaz, Javier Otero, Francisco Brenes, Joaquı́n Carballido, José Molero, Antonio Fernández‐Pro Ledesma, José Manuel Cózar Olmos, J. Dalmau, Isaac Subirana Cachinero, Michael Herdman, Vincenzo Ficarra
Almmustuhtton 2018Revisão
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Cancer
Pathology
Urology
Meta-analysis
Renal cell carcinoma
Adverse effect
Alternative medicine
Cancer research
Clear cell renal cell carcinoma
Immunohistochemistry
Kidney cancer
Oncology
Placebo
Randomized controlled trial
Biology
Clinical trial
Environmental health
Fibroblast activation protein, alpha
Immunotherapy
Mirabegron
Overactive bladder
Population
Prostate
Prostate cancer
Stromal cell
Surgery
Tolterodine
Urinary system